3 Profitable Stocks That Concern Us

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here are three profitable companies that don’t make the cut and some better opportunities instead.

Mission Produce (AVO)

Trailing 12-Month GAAP Operating Margin: 4.6%

Founded in 1983 in California, Mission Produce (NASDAQ:AVO) grows, packages, and distributes avocados.

Why Are We Hesitant About AVO?

1. Revenue base of $1.25 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
2. Commoditized products, bad unit economics, and high competition are reflected in its low gross margin of 11.6%
3. ROIC of 4.6% reflects management’s challenges in identifying attractive investment opportunities

At $13.24 per share, Mission Produce trades at 18.4x forward P/E. Read our free research report to see why you should think twice about including AVO in your portfolio.

CSX (CSX)

Trailing 12-Month GAAP Operating Margin: 34.2%

Established as part of the Chessie System and Seaboard Coast Line Industries merger, CSX (NASDAQ:CSX) is a transportation company specializing in freight rail services.

Why Do We Steer Clear of CSX?

1. Weak unit sales over the past two years indicate demand is soft and that the company may need to revise its strategy
2. Flat earnings per share over the last two years lagged its peers
3. Free cash flow margin shrank by 6.2 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive

CSX’s stock price of $51 implies a valuation ratio of 23.7x forward P/E. Check out our free in-depth research report to learn more about why CSX doesn’t pass our bar.

Pediatrix Medical Group (MD)

Trailing 12-Month GAAP Operating Margin: 11%

With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE:MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.

Why Does MD Give Us Pause?

1. Customers postponed purchases of its products and services this cycle as its revenue declined by 1.3% annually over the last two years
2. Smaller revenue base of $1.95 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
3. Projected sales growth of 1.3% for the next 12 months suggests sluggish demand

Pediatrix Medical Group is trading at $25.98 per share, or 11.2x forward P/E. If you’re considering MD for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.